GlassScriptPhysician profile
John Nicholas Govostes
NPI 1457507261
$1,303.08
in general payments reported to CMS, 2019-2025
7 companies · $96.51 in 2025
The $96.51 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $54.56 · 2021: $40.56 · 2022: $188 · 2023: $146 · 2024: $529 · 2025: $96.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.99 |
| Education | $145.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Keystone Dental INC. | $1,048.72 | 2019-2025 | |
| Straumann USA LLC | $107.86 | 2020-2025 | |
| Biohorizons Implant Systems INC. | $54.69 | 2020-2021 | |
| Zest Holdings, LLC | $50.92 | 2024 | |
| Dentsply Sirona Orthodontics INC | $15.23 | 2019 | |
| 3m Company | $14.01 | 2020 | |
| Philips North America LLC | $11.65 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Govostes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.